NewsEpisurf Medical reaches milestone of 200 implants

Episurf Medical announces that the 200th implantation of the Episealer knee implant has been scheduled for the coming days. Episurf Medical’s unique, personalised technology continues to gain traction, enabling orthopaedic surgeons to successfully treat previously difficult to treat patients with cartilage and underlying bone lesions of the knee joint.

“This is a significant milestone for Episurf Medical”, says Pål Ryfors, Acting CEO and CFO of Episurf Medical. “Our 200th Episealer implantation now clearly demonstrates that our technology is being accepted by more and more orthopaedic surgeons with patients continuing to report how our products change their lives”.

Dennis Stripe, Executive Chairman of the Board comments that “Episurf Medical is changing the treatment pathway for patients with knee injuries. Our technology continues to be accepted by specialist surgeons who see for themselves the impact the Episealer has on their patients”.

For more information, please contact:
Pål Ryfors, acting CEO, Episurf Medical
Tel: +46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com